Patent infringement risk can cost companies hundreds of millions of dollars and carries with it the threat of triple damages in cases of willfulness. And while in recent history the possibility of large verdicts seemed unlikely, over the past year the industry has seen a sudden increase in billion-dollar mega-verdicts, some with willfulness enhancements.
With an overabundance of data, new and numerous communication channels, and an increasingly transient and remote workforce, how do counsel for modern innovators manage freedom-to-operate investigations? How are communications kept privileged while facilitating collaboration between legal and R&D teams? What is the appropriate balance between unfettered product innovation and managing patent risk?
Join Gene Quinn, on Wednesday, September 22, at 12 PM ET for a discussion about where focus should be placed in order to maximize value and insight in patent clearance in the wake of a resurgence in large scale patent damage awards. Joining Gene for this conversation will be patent litigator Christopher Patrick, Special Counsel at Baker Botts, Jennifer Russell, Associate General Counsel for Intellectual Property for Surgalign Spine Technologies, Inc., and Gabe Sukman, Co-Founder and CEO, ClearstoneIP.
In addition to taking questions from the audience, the panel will discuss: